Uncategorized

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Artificial intelligence tools could help safety-net organizations close gaps created by massive cuts to Medicaid signed into law last year, experts said at the HIMSS conference.

Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.

Los dispositivos de visión nocturna modernos son equipos de alta tecnología capaces de realizar diversas tareas en la oscuridad. Sin embargo, su desarrollo se ha ralentizado recientemente, lo que ha impulsado a los ingenieros a buscar maneras de llevar la óptica de visión …

After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice. But recent decisions call into question whether shared evidence and prior knowledge will accelerate development in rare diseases.

Advita Ortho was formed after orthopedic implant maker Exactech sold its assets in bankruptcy.

IT developers who lose their certification would also forfeit some financial incentives, ASTP/ONC head Dr. Thomas Keane said at the HIMSS conference.

  Aunque parece que el Bitcoin es algo novedoso, lo cierto es que ya lleva entre nosotros 17 años. Pese a ello, es un activo financiero que pocas personas comprenden.   Siempre se suele decir que es una moneda digital o que se trata de un sistema descentralizado, pero nadie sab …

The technology giant is the latest in a string of companies to roll out an AI tool specific to consumers’ health queries.

Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could alter the drug’s toxicity profile and pose safety risks to patients, the company said in an open letter.